CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade Covetrus - CVET CFD

    Market is not available at the moment

    Market information is presented
    as of 2023-09-21

    • Summary
    Trading Conditions
    Spread 0.09
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026151 %
    Charges from full value of position ($-4.97)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026151%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.003929 %
    Charges from full value of position ($0.75)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.003929%
    Overnight fee time 21:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 5%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    Covetrus Inc ESG Risk Ratings

    High Medium Low Negligible

    ‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

    More ESG coverage

    Key Stats
    Prev. Close* 20.65
    Open* 20.65
    1-Year Change* -0.1%
    Day's Range* 20.64 - 20.67
    52 wk Range 13.39-21.20
    Average Volume (10 days) 2.17M
    Average Volume (3 months) 26.09M
    Market Cap 2.94B
    P/E Ratio -100.00K
    Shares Outstanding 139.97M
    Revenue 4.65B
    EPS -0.09
    Dividend (Yield %) N/A
    Beta 1.50
    Next Earnings Date Nov 2, 2022

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    Date Close Change Change (%) Open High Low
    Jun 29, 2022 20.67 0.05 0.24% 20.62 20.68 20.62
    Jun 28, 2022 20.65 -0.05 -0.24% 20.70 20.73 20.61
    Jun 27, 2022 20.70 0.06 0.29% 20.64 20.73 20.64
    Jun 24, 2022 20.68 -0.02 -0.10% 20.70 20.75 20.67
    Jun 23, 2022 20.67 0.07 0.34% 20.60 20.74 20.58
    Jun 22, 2022 20.59 0.16 0.78% 20.43 20.65 20.43
    Jun 21, 2022 20.61 0.04 0.19% 20.57 20.61 20.52
    Jun 17, 2022 20.56 0.07 0.34% 20.49 20.56 20.47
    Jun 16, 2022 20.48 -0.02 -0.10% 20.50 20.58 20.45
    Jun 15, 2022 20.52 0.02 0.10% 20.50 20.57 20.45
    Jun 14, 2022 20.46 -0.01 -0.05% 20.47 20.62 20.39
    Jun 13, 2022 20.60 0.23 1.13% 20.37 20.65 20.37
    Jun 10, 2022 20.66 -0.02 -0.10% 20.68 20.69 20.62
    Jun 9, 2022 20.70 0.02 0.10% 20.68 20.70 20.65
    Jun 8, 2022 20.69 0.10 0.49% 20.59 20.73 20.59
    Jun 7, 2022 20.72 0.10 0.48% 20.62 20.72 20.62
    Jun 6, 2022 20.64 -0.06 -0.29% 20.70 20.70 20.62
    Jun 3, 2022 20.66 0.10 0.49% 20.56 20.69 20.56
    Jun 2, 2022 20.64 -0.02 -0.10% 20.66 20.69 20.61
    Jun 1, 2022 20.64 -0.10 -0.48% 20.74 20.76 20.61

    Covetrus Events

    Time (UTC) Country Event
    No events scheduled
    View all events
    • Annual
    • Quarterly
    2021 2020 2019 2018 2017
    Total revenue 4575 4339 3976 3777.99 3579.79
    Revenue 4575 4339 3976 3777.99 3579.79
    Cost of Revenue, Total 3717 3541 3227 3093.88 2927.77
    Gross Profit 858 798 749 684.112 652.025
    Total Operating Expense 4598 4334 4973 3640.9 3444.47
    Selling/General/Admin. Expenses, Total 720 707 660 538.469 516.703
    Unusual Expense (Income) 0 -74 938 8.545 0
    Operating Income -23 5 -997 137.098 135.322
    Interest Income (Expense), Net Non-Operating -32 -46 -54 2.975 2.528
    Other, Net 1 17 22 3.104 0.919
    Net Income Before Taxes -54 -24 -1029 143.177 138.769
    Net Income After Taxes -54 -17 -983 110.515 111.104
    Minority Interest 0 -2 3 -6.521 -27.69
    Equity In Affiliates 0 0 1.233 1.294
    Net Income Before Extra. Items -54 -19 -980 105.227 84.708
    Net Income -54 -19 -980 100.861 64.354
    Income Available to Common Excl. Extra. Items -54 -19 -980 105.227 84.708
    Income Available to Common Incl. Extra. Items -54 -19 -980 100.861 64.354
    Diluted Net Income -54 -19 -980 100.861 64.354
    Diluted Weighted Average Shares 137 118 107 111.339 111.193
    Diluted EPS Excluding Extraordinary Items -0.39416 -0.16102 -9.15888 0.94511 0.76181
    Dividends per Share - Common Stock Primary Issue 0
    Diluted Normalized EPS -0.14599 -0.25466 -3.15701 1.00435 0.76181
    Total Extraordinary Items -4.366 -20.354
    Depreciation / Amortization 161 160 148
    Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
    Total revenue 1148 1122 1162 1189 1102
    Revenue 1148 1122 1162 1189 1102
    Cost of Revenue, Total 923 910 946 969 892
    Gross Profit 225 212 216 220 210
    Total Operating Expense 1142 1129 1166 1198 1105
    Selling/General/Admin. Expenses, Total 191 189 188 196 179
    Depreciation / Amortization 28 30 32 33 34
    Operating Income 6 -7 -4 -9 -3
    Interest Income (Expense), Net Non-Operating -7 -6 -8 -9 -9
    Other, Net 2 3 -2 0 0
    Net Income Before Taxes 1 -10 -14 -18 -12
    Net Income After Taxes -2 -3 -4 -31 -16
    Minority Interest 0 0 0 0 0
    Net Income Before Extra. Items -2 -3 -4 -31 -16
    Net Income -2 -3 -4 -31 -16
    Income Available to Common Excl. Extra. Items -2 -3 -4 -31 -16
    Income Available to Common Incl. Extra. Items -2 -3 -4 -31 -16
    Diluted Net Income -2 -3 -4 -31 -16
    Diluted Weighted Average Shares 138 134 137 137 136
    Diluted EPS Excluding Extraordinary Items -0.01449 -0.02239 -0.0292 -0.22628 -0.11765
    Dividends per Share - Common Stock Primary Issue 0 0 0 0 0
    Diluted Normalized EPS -0.0192 0.11828 -0.02445 -0.22153 -0.10331
    Unusual Expense (Income) 0
    • Annual
    • Quarterly
    2021 2020 2019 2018 2017
    Total Current Assets 1351 1420 1340 1086.6 1076.93
    Cash and Short Term Investments 183 290 130 23.324 16.656
    Cash & Equivalents 183 290 130 23.324 16.656
    Total Receivables, Net 555 574 493 480.009 503.517
    Accounts Receivable - Trade, Net 480 507 426 430.783 427.866
    Total Inventory 583 530 636 564.163 534.664
    Prepaid Expenses 30 26 30 19.109 22.089
    Total Assets 3410 3496 3359 2233.08 2217.02
    Property/Plant/Equipment, Total - Net 281 233 177 68.549 64.554
    Property/Plant/Equipment, Total - Gross 416 339 261 142.057 128.16
    Accumulated Depreciation, Total -135 -106 -84 -73.508 -63.606
    Goodwill, Net 1247 1187 1154 749.762 759.768
    Intangibles, Net 439 555 643 208.213 252.927
    Long Term Investments 49 52 45 21.678 22.974
    Other Long Term Assets, Total 43 49 98.277 39.871
    Total Current Liabilities 698 691 829 572.563 511.586
    Accounts Payable 442 411 520 441.453 375.782
    Accrued Expenses 151 183 63 36.948 33.382
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 32 1 62 0.675 3.204
    Other Current Liabilities, Total 73 96 184 93.487 99.218
    Total Liabilities 1899 1959 2106 739.467 959.781
    Total Long Term Debt 1014 1068 1125 23.529 23.529
    Long Term Debt 1014 1068 1125 23.529 23.529
    Deferred Income Tax 13 28 48 16.372 18.908
    Minority Interest 23 36 10 92.432 366.554
    Other Liabilities, Total 151 136 94 34.571 39.204
    Total Equity 1511 1537 1253 1493.62 1257.24
    Retained Earnings (Accumulated Deficit) -1081 -1027 -1001 1575.83 1299.23
    Other Equity, Total -79 -66 -86 -82.214 -41.988
    Total Liabilities & Shareholders’ Equity 3410 3496 3359 2233.08 2217.02
    Total Common Shares Outstanding 138.012 136.018 111.621 111.193 111.193
    Other Current Assets, Total 51
    Common Stock 1 1 1
    Additional Paid-In Capital 2670 2629 2339
    Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
    Total Current Assets 1417 1351 1351 1419 1422
    Cash and Short Term Investments 117 183 187 230 211
    Cash & Equivalents 117 183 187 230 211
    Total Receivables, Net 627 555 568 596 605
    Accounts Receivable - Trade, Net 538 480 491 517 518
    Total Inventory 630 583 552 557 555
    Prepaid Expenses 43 30 44 36 51
    Total Assets 3470 3410 3420 3414 3440
    Property/Plant/Equipment, Total - Net 285 281 247 229 229
    Property/Plant/Equipment, Total - Gross 289 279 252 242 230
    Accumulated Depreciation, Total -142 -135 -125 -120 -112
    Goodwill, Net 1267 1247 1247 1187 1187
    Intangibles, Net 414 439 479 484 516
    Long Term Investments 48 49 96 95 86
    Total Current Liabilities 762 698 714 709 682
    Accounts Payable 507 442 428 427 416
    Accrued Expenses 52 63 62 55 57
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 52 32 46 31 17
    Other Current Liabilities, Total 151 161 178 196 192
    Total Liabilities 1942 1899 1918 1912 1920
    Total Long Term Debt 995 1014 1027 1040 1054
    Long Term Debt 995 1014 1027 1040 1054
    Deferred Income Tax 12 13 18 16 23
    Minority Interest 22 23 23 23 36
    Other Liabilities, Total 151 151 136 124 125
    Total Equity 1528 1511 1502 1502 1520
    Common Stock 1 1 1 1 1
    Additional Paid-In Capital 2691 2670 2659 2641 2637
    Retained Earnings (Accumulated Deficit) -1083 -1081 -1078 -1074 -1043
    Other Equity, Total -81 -79 -80 -66 -75
    Total Liabilities & Shareholders’ Equity 3470 3410 3420 3414 3440
    Total Common Shares Outstanding 139.143 138.012 137.732 137.36 136.342
    Other Long Term Assets, Total 39 43
    • Annual
    • Quarterly
    2021 2020 2019 2018 2017
    Net income/Starting Line -54 -17 -1022 107.382 92.044
    Cash From Operating Activities 102 53 103 157.904 108.191
    Cash From Operating Activities 171 166 155 64.1 59.053
    Deferred Taxes -22 -32 -25 -4.8 6.186
    Non-Cash Items 99 2 1000 6.609 6.953
    Cash Taxes Paid 27 24 18 11.767 7.698
    Changes in Working Capital -92 -66 -5 -15.387 -56.045
    Cash From Investing Activities -140 -5 -65 -29.368 -128.526
    Capital Expenditures -60 -58 -39 -22.025 -20.665
    Other Investing Cash Flow Items, Total -80 53 -26 -7.343 -107.861
    Cash From Financing Activities -66 104 66 -119.695 15.036
    Financing Cash Flow Items -36 -28 58 -117.591 15.35
    Issuance (Retirement) of Debt, Net -30 -122 1177 -2.104 -0.314
    Foreign Exchange Effects -3 8 3 -2.173 2.241
    Net Change in Cash -107 160 107 6.668 -3.058
    Cash Interest Paid 22 40 47
    Total Cash Dividends Paid 0 -6 -1174
    Issuance (Retirement) of Stock, Net 0 260 5
    Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
    Net income/Starting Line -2 -54 -51 -47 -16
    Cash From Operating Activities -33 102 58 -1 -59
    Cash From Operating Activities 40 171 128 86 43
    Deferred Taxes 1 -22 -16 -11 -3
    Non-Cash Items 22 99 68 45 18
    Changes in Working Capital -94 -92 -71 -74 -101
    Cash From Investing Activities -29 -140 -119 -24 -13
    Capital Expenditures -11 -60 -38 -24 -13
    Other Investing Cash Flow Items, Total -18 -80 -81 0 0
    Cash From Financing Activities -5 -66 -37 -34 -3
    Financing Cash Flow Items -5 -36 -37 -14 -3
    Issuance (Retirement) of Debt, Net 0 -30 0 0 0
    Foreign Exchange Effects 1 -3 -5 -1 -4
    Net Change in Cash -66 -107 -103 -60 -79
    Total Cash Dividends Paid 0 0 0
    Issuance (Retirement) of Stock, Net 0 0 -20

    Covetrus Company profile

    About Covetrus Inc

    Covetrus, Inc. is an animal-health technology and services company. The Company operates through three segments: North America, Europe, and Asia Pacific (APAC) & Emerging Markets. The Company's products and services include supply chain services, software services, and prescription management. The supply chain services offers a portfolio of products and services and value-added solutions for enhancing operating efficient practices and delivering animal care. Software services develops, provides, and supports veterinary practices with a range of veterinary software systems. This includes practice management software, data-driven applications, client communications tools, and related services. The prescription management platform, which integrates into veterinary practice management software and workflow, client engagement and outreach communications, and integrated veterinary-pharmacy services and is designed to improve medical compliance.

    Financial summary

    BRIEF: For the fiscal year ended 31 December 2021, Covetrus Inc revenues increased 5% to $4.58B. Net loss increased from $19M to $54M. Revenues reflect North America segment increase of 14% to $2.72B, APAC & Emerging Markets segment increase of 15% to $461M. Higher net loss reflects Selling, general and administrative increase of 2% to $720M (expense), Depreciation in SGA increase of 7% to $32M (expense).

    Industry: Medical Equipment, Supplies & Distribution (NEC)

    7 Custom House St
    PORTLAND
    MAINE 04101-4185
    US

    News

    EUR/USD tests key support

    EUR/USD is currently testing a key support level after the Federal Reserve indicated a potential extension of higher interest rates.

    14:32, 21 September 2023
    Bank of England building

    BoE leaves rates unchanged, GBP drops further as investors look for more clarity

    The Bank of England has left rates unchanged at 5.25% with a 5-4 vote split after CPI dropped more than expected in August

    11:45, 21 September 2023
    British banknotes and coins photographed directly above. The coins are in a stack, placed on top of the banknotes.

    GBP softer after CPI surprise, JPY focused on any further hints from Ueda

    GBP drops after a softer CPI reading scares investors about the BoE intentions. JPY on the lookout for further policy tweaks from Governor Ueda.

    12:42, 20 September 2023

    How to Trade The Break & Retest

    In this week's instalment, we delve into the Break & Retest pattern—a strategic approach to navigating breakout trades. If you've wrestled with the frustration of false breakouts, incorporating this pattern into your trading toolkit may help you overcome this challenge and put you on the path to becoming a more confident and consistent trader.

    11:59, 20 September 2023

    Cable coils near lows ahead of Fed and BoE rate decisions

    It’s a big week for Cable (GBP/USD) as both the Federal Reserve and the Bank of England are set to make crucial rate decisions.

    14:16, 19 September 2023

    FTSE 100 Technical Outlook - 18 September 2023

    In prior technical outlooks, we highlighted the importance of staying alert in sleepy markets, and last Thursday’s developments on the FTSE 100 serve as a prime illustration of this principle.

    06:55, 19 September 2023
    View of the City of London’s illuminated financial district skyline at dusk

    Market Analysis: FTSE 100 boosted by ECB rate hike end and iron ore rally

    The FTSE 100 rose over 2% on Thursday as the ECB announced no more rate hikes for now.

    13:46, 15 September 2023

    People also watch

    BTC/USD

    26,625.25 Price
    -0.030% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 21:00 (UTC)
    Spread 85.00

    Oil - Crude

    90.14 Price
    +0.770% 1D Chg, %
    Long position overnight fee 0.0415%
    Short position overnight fee -0.0634%
    Overnight fee time 21:00 (UTC)
    Spread 0.030

    XRP/USD

    0.52 Price
    +0.700% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 21:00 (UTC)
    Spread 0.01192

    ETH/USD

    1,598.51 Price
    +0.560% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 21:00 (UTC)
    Spread 5.40

    Still looking for a broker you can trust?

    Join the 555.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading